45 research outputs found
Nullius in verba: "Canakinumab for the Treatment of Autoinflammatory Recurrent Fever Syndromes" in NEJM
Get PDFArticle by De Benedetti and colleagues, the leading scientists in the relevant field, about canakinumab for autoinflammatory recurrent fever syndromes, which was recently published in the New England Journal of Medicine (1). I would like to raise some worthwhile issues that need to be clarified
Comment on the TARGET trial by Bennell et al.: was the interpretation of similar improvement based on equivalence analysis?
No full text
Comment on “Seasonal variations of Google searches for joint swelling: implications for patient-reported outcomes”
No full text
